Profile
| Metric | Value |
|---|---|
| Full Name | Viatris Inc. |
| Ticker | NASDAQ: VTRS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | viatris.com |
| Employees | 32,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $12.40 | |
| Price, 1D Change | +0.24% | |
| Market Cap | $14B | |
| TTM Dividend Yield | 3.87% | |
| PE Ratio | - | |
| Beta | 0.81 | |
| Revenue | $15B | |
| Revenue, 1Y Change | -4.37% | |
| EPS | -$0.53 | |
| EPS, 1Y Change | -1,273.29% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.12 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 3:2 | |
| Next Split | N/A | N/A |
| Last Ticker Change | VTRSV | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.53 | |
| EPS Estimate | $2.31 | |
| EPS Est. Change | +533.94% | |
| Revenue | $14.71B | |
| Revenue Estimate | $14.10B | |
| Revenue Est. Change | -4.16% | |
| Current Price | $12.40 | |
| Price Target | - | $13.00 |
| Price Tgt. Change | - | +4.84% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.95 | $0.05 | -98.46% | |
| $2.68 | -$0.53 | -119.82% | |
| $2.31 | N/A | +533.94% | |
| $2.46 | N/A | +563.35% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $15.45B | $15.38B | -0.46% | |
| $14.82B | $14.71B | -0.73% | |
| $14.10B | N/A | -4.16% | |
| $14.28B | N/A | -2.94% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +3.77% | |
| Price, 3Y | +2.48% | |
| Market Cap, 1Y | +0.13% | |
| Market Cap, 3Y | -2.76% | |
| Revenue, 1Y | -4.37% | |
| Revenue, 3Y | -17.62% | |
| EPS, 1Y | -1,273.29% | |
| EPS, 3Y | +49.38% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $12.40 | |
| SMA 200 | $9.69 | |
| SMA 200 vs Price | -21.87% | |
| SMA 50 | $11.12 | |
| SMA 50 vs Price | -10.33% | |
| Beta | 0.81 | |
| ATR | $0.28 | |
| 14-Day RSI | 72.83 | |
| 10-Day Volatility | 12.81% | |
| 1-Year Volatility | 35.65% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.12 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 3.87% | |
| Total Dividend | $0.48 | |
| Dividends Paid | $574.80M | |
| Payout Ratio | -90.63% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $14.71B | |
| EPS | -$0.53 | |
| Gross Profit | $6.22B | |
| Gross Margin | 42.32% | |
| Operating Profit | $1.86B | |
| Operating Margin | -45.03% | |
| Net Income | -$634.20M | |
| Net Margin | -4.31% | |
| EBITDA | $4.57B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.77 | |
| Current Ratio | 1.56 | |
| Quick Ratio | 0.89 | |
| - | ||
| F-Score | 5 | |
| Altman Z-Score | 1.09 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 1.02 | |
| PB Ratio | 0.94 | |
| EV/EBITDA | 7.37 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $18.64B | |
| Cash & Equivalents | $829.60M | |
| Total Assets | $41.50B | |
| Current Assets | $8.99B | |
| Total Liabilities | $22.87B | |
| Current Liabilities | $5.78B | |
| Total Debt | $14.31B | |
| Short Term Debt | $95.40M | |
| Accounts Payable | $1.36B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $15.34B | |
| Operating Expenses | $4.36B | |
| Cost Of Goods Sold | $8.49B | |
| SG&A | $0.00 | |
| D&A | $2.71B | |
| Interest Expense | $0.00 | |
| Income Tax | $11.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $2.30B | |
| CFI | $1.80B | |
| CFF | -$4.33B | |
| Capex | $359.10M | |
| Free Cash Flow | $1.94B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | ||
| Truist Securities | ||
| Goldman Sachs | ||
| Jefferies | → | |
| Piper Sandler | → | |
| Barclays | → | |
| B of A Securities | → | |
| Piper Sandler | → | |
| Barclays | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with VTRS
Data Sources & References
- VTRS Official Website www.viatris.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1792044/000179204425000046/0001792044-25-000046-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1792044/000179204425000008/0001792044-25-000008-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- VTRS Profile on Yahoo Finance finance.yahoo.com/quote/VTRS
- VTRS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vtrs
FAQ
What is the ticker symbol for Viatris Inc.?
The ticker symbol for Viatris Inc. is NASDAQ:VTRS
Does Viatris Inc. pay dividends?
Yes, Viatris Inc. pays dividends. The last payment was $0.12, with an ex-dividend date on November 24, 2025
What sector is Viatris Inc. in?
Viatris Inc. is in the Healthcare sector
What industry is Viatris Inc. in?
Viatris Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Viatris Inc. based in?
Viatris Inc. is headquartered in United States
When did Viatris Inc. go public?
Viatris Inc. initial public offering (IPO) was on March 17, 1980
Is Viatris Inc. in the S&P 500?
Yes, Viatris Inc. is included in the S&P 500 index
Is Viatris Inc. in the NASDAQ 100?
No, Viatris Inc. is not included in the NASDAQ 100 index
Is Viatris Inc. in the Dow Jones?
No, Viatris Inc. is not included in the Dow Jones index
When was Viatris Inc. last earnings report?
Viatris Inc.'s most recent earnings report was on November 6, 2025
When does Viatris Inc. report earnings?
The next expected earnings date for Viatris Inc. is February 26, 2026